Tci Wealth Advisors, Inc. Cor Medix Inc. Transaction History

Tci Wealth Advisors, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$2.82 - $7.52 $282 - $752	-100 Reduced 50.0%	100 $0
Q3 2021 Oct 29, 2021	SELL	$4.46 - $7.11 $669 - $1,066	-150 Reduced 42.86%	200 $1,000
Q2 2021 Aug 02, 2021	SELL	$6.05 - $10.09 $3,327 - $5,549	-550 Reduced 61.11%	350 $2,000
Q1 2021 Apr 29, 2021	SELL	$6.84 - $17.58 $2,736 - $7,031	-400 Reduced 30.77%	900 $9,000
Q4 2020 Jan 21, 2021	SELL	$5.0 - $9.15 $25 - $45	-5 Reduced 0.38%	1,300 $10,000
Q3 2020 Oct 20, 2020	SELL	$3.96 - $6.15 $396 - $615	-100 Reduced 7.12%	1,305 $8,000
Q3 2019 Oct 17, 2019	BUY	$6.38 - $9.69 $8,963 - $13,614	1,405 New	1,405 $9,000
Q2 2019 Jul 23, 2019	SELL	$5.93 - $10.57 $11,296 - $20,135	-1,905 Closed	0 $0
Q1 2019 Apr 11, 2019	BUY	$6.95 - $13.25 $13,239 - $25,241	1,905 New	1,905 $18,000

104

17.4M

134K

441K

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $426M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.